Resistant hypertension is linked to an increased risk for cardiovascular outcomes in type 1 diabetes, with renal damage accounting for a large part of the association, say researchers.
Baseline diastolic blood pressure does not influence the cardiovascular gains from reducing systolic blood pressure in people with type 2 diabetes using a standard glucose-lowering regimen, indicates a secondary analysis of ACCORD data.
The quality of care among older adults with diabetes declines with increasing comorbidity and is particularly low for those with both osteoarthritis and major depression, population-based study data show.
Advisory Board member Pamela Dyson underlines the key features for healthcare professionals working in diabetes education, diabetes management, type 2 diabetes prevention, and cardiovascular risk reduction.
Editorial Board member Sanjay Kalra presents a pragmatic approach to the use of glucagon-like peptide-1 receptor agonists in patients affected by acute myocardial infarction.